Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

4424 - Selective Accumulation of the Rat Adherent Natural Killer Cells in Mammary Tumor Tissues

Date

11 Sep 2017

Session

Poster display session

Presenters

Shouzhi Gu

Citation

Annals of Oncology (2017) 28 (suppl_5): v1-v21. 10.1093/annonc/mdx361

Authors

S. Gu

Author affiliations

  • School Of Rehabilitation Sciences, Seirei Christopher University, 433-8558 - Hamamatsu/JP
More

Resources

Abstract 4424

Background

In the present study, we attempted to clarify what kind of adhesion molecules and tumor cytotoxic killer activity A-NK cells can express, when cultured for long period in vitro, and then tried experimentally to augment the selective accumulation the A-NK cells into rat mammary tumors, in combination with the prior injection of various kinds of adjuvants into the tumor region. The mechanisms by which the effector cells accumulate in tumor tissue will be discussed.

Methods

1. Animals: Specific pathogen-free (SPF) female rats. 2. Preparation of A-NK cells: A-NK cells were isolated from splenic lymphocytes. 3. Antibodies: Monoclonal antibodies, and Anti adhesion molecule antibodies. 4. Immunohistochemical staining and Flow cytometric analysis. 5. Preparation of mammary tumor bearing rats.

Results

Immunocytochemical and flow-cytometric analysis revealed that most of the A-NK cells strongly expressed lymphocyte-function-associated antigen 1 throughout the incubation. All A-NK cells from 8-150-day cultures, particularly those cultured for 8 days, showed significant cytolytic activity against all targets. Peritumoral injection of various kinds of adjuvant, particularly Freund's complete adjuvant plus bacillus Calmetee-Guerin, resulted in a marked accumulation of A-NK cells in mammary tumor tissues 24 h after injection, and simultaneously in the formation of vessels resembling high-endothelium venules, and expression of the ICAM-1 molecule on the tumor cells in the sites of tumor tissues. When A-NK cells were intravenously administered, significant retardation of tumor growth and prolongation of survival of tumor-bearing rats were observed in the groups that received the prior injection of adjuvants.

Conclusions

These results indicate that the prior injection of proper adjuvant into the peritumoral region is effective for the selective accumulation or infiltration of A-NK cells into the sites of tumor tissues, and results in the marked retardation of tumor growth.

Clinical trial identification

none

Legal entity responsible for the study

School of Rehabilitation Sciences

Funding

None

Disclosure

The author has declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.